Membrane and use thereof
    2.
    发明申请
    Membrane and use thereof 失效
    膜及其用途

    公开(公告)号:US20060138044A1

    公开(公告)日:2006-06-29

    申请号:US10532131

    申请日:2003-10-17

    IPC分类号: B01D71/68

    摘要: The membrane producible by shaping a polymer blend or a block copolymer comprising blocks of monomer units, loading the polymer blend or block copolymer with a blowing gas concentration within the polymer blend or block polymer above a critical concentration at a temperature below a critical temperature, but above the glass transition temperature of the polymer blend/gas or block copolymer/gas mixture and finally stabilizing the foam structure is characterized in that as polymer blend a homogeneous polymer blend comprising at least one hydrophilic and at least one hydrophobic polymer and/or a block copolymer of alternating blocks of hydrophilic and hydrophobic monomer units is used, both the polymer blend and the block copolymer having a solubility relating to the used foaming gas above the critical concentration. The said membrane is used for medical purposes, especially for the haemodialysis, haemofiltration, haemodiafiltration, plasmapherese, immunotherapy, micro- or ultrafiltration or gas separation.

    摘要翻译: 该膜可以通过将包含单体单元的嵌段的聚合物共混物或嵌段共聚物成型,将聚合物共混物或嵌段共聚物以高于临界温度的临界浓度的聚合物共混物或嵌段聚合物内的吹入气体浓度加载, 高于聚合物共混物/气体或嵌段共聚物/气体混合物的玻璃化转变温度,并且最终稳定泡沫结构的特征在于,作为聚合物共混物,包含至少一种亲水和至少一种疏水性聚合物和/或嵌段的均匀聚合物共混物 使用亲水和疏水单体单元的交替嵌段的共聚物,聚合物共混物和嵌段共聚物具有高于临界浓度的所用发泡气体的溶解度。 所述膜用于医疗目的,特别用于血液透析,血液透析,血液透析,血浆置换,免疫治疗,微量或超滤或气体分离。

    Permselective membrane and process for manufacturing thereof
    4.
    发明申请
    Permselective membrane and process for manufacturing thereof 有权
    选择性渗透膜及其制造方法

    公开(公告)号:US20060234582A1

    公开(公告)日:2006-10-19

    申请号:US10540123

    申请日:2003-12-17

    摘要: The present invention relates to a membrane being suitable for, for example, hemodialysis. Said membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer. According to the present invention the outer surface of the hollow fiber has pores in the range of 0.5-3 μm and the numbers of said pores in the outer surface are in the range of 10,000 to 150,000 pores per mm2, preferably in the range of 18,000 to 100,000 pores per mm2, and most preferably in the range of 20,000 to 100,000 pores per mm2. The present invention further relates to a process for the preparation of said membrane and use of said membrane in hemodialysis, hemodiafiltration and hemofiltration, and in dialysis and filtration in general, for example in water purification or dehydration.

    摘要翻译: 本发明涉及一种适用于例如血液透析的膜。 所述膜包含至少一种疏水性聚合物和至少一种亲水性聚合物。 根据本发明,中空纤维的外表面具有在0.5-3μm范围内的孔,并且外表面中的所述孔的数量在每平方毫米2的10,000-15,000个孔的范围内 >,优选在每毫米2至18,000至100,000个孔的范围内,最优选在20,000至100,000个孔/ mm 2的范围内。 本发明还涉及一种制备所述膜的方法和所述膜在血液透析,血液透析滤过和血液滤过中的用途,以及在透析和过滤中,通常例如在水净化或脱水中。

    Polymer affinity matrix, a method for the production and use thereof
    8.
    发明申请
    Polymer affinity matrix, a method for the production and use thereof 审中-公开
    聚合物亲和基质,其生产和使用方法

    公开(公告)号:US20060134595A1

    公开(公告)日:2006-06-22

    申请号:US10520532

    申请日:2003-07-04

    IPC分类号: A01N1/02 A61K47/48

    摘要: A polymer affinity matrix for the binding of one or more substances in a fluid for removing said substance(s) from the fluid and/or decreasing the amount or concentration thereof in said fluid with a view to preventing, eliminating, or reducing undesired activation of components in said fluid is described, as well as a method for removing said substance(s) from the fluid and/or decreasing the amount or concentration thereof in said fluid, a method for the production of said matrix, use of said matrix and a kit comprising said matrix. The polymer affinity matrix comprises a solid support, a space and a ligand, containing arginine as a binding unit.

    摘要翻译: 用于结合流体中的一种或多种物质以从流体中除去所述物质和/或降低其中所述物质的量或浓度的聚合物亲和基质,以防止,消除或减少不期望的活化 所述流体中的组分以及用于从流体中除去所述物质和/或减少所述流体中的量或浓度的方法,生产所述基质的方法,所述基质的使用和 试剂盒包括所述基质。 聚合物亲和基质包含含有精氨酸作为结合单元的固体支持物,空间和配体。